This article is more than 5 years old. Information may no longer be current.

Conmed announces new interim CEO, other leadership changes

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Conmed Corporation announced that Joseph Corasanti, CEO, president and member of the company’s board of directors, is stepping down, and the board of directors has appointed Curt Hartman as interim CEO, effective immediately.

Hartman, an independent director of Conmed, most recently was interim CEO and chief financial officer of Stryker Corporation, according to a Conmed press release.

Conmed’s board has also appointed Charles Farkas, a senior partner at Bain & Company and former North American head of Bain’s Healthcare Practice, as a new independent director, effective immediately.

A group comprising independent board members, including Farkas, will commence the search for potential permanent CEO candidates, according to the release.

In other developments, Conmed announced that its founder, Eugene Corasanti, has retired from the board and as a company employee after 44 years of service, effective immediately.

The company also announced that Bill Abraham is retiring as executive vice president of business development, effective as of the conclusion of a transition period expected to be no later than Sept. 30, 2014.